A new interventional study shows that a blood test can reveal who still has microscopic traces of bladder cancer after surgery – and may therefore benefit from immunotherapy. The approach is more precise than current guidelines, and for 60% of those treated, cancer DNA disappeared from the blood and scans showed no signs of disease.
